StoxAnupam Rasayan India vs Privi Speciality Chemicals: share price & financials comparison
NSE: ANURAS vs PRIVISCL · Chemicals · as of 06 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Anupam Rasayan India vs Privi Speciality Chemicals at a glance
Anupam Rasayan India (ANURAS) has a market capitalisation of ₹13,266 Cr, against ₹13,145 Cr for Privi Speciality Chemicals (PRIVISCL). Over the past year Privi Speciality Chemicals has returned +17.8%, compared with +7.0% for Anupam Rasayan India. On valuation, Privi Speciality Chemicals trades at a lower P/E of 47.1 versus 75.9. Privi Speciality Chemicals earns a higher return on equity (17.7% vs 5.2%). Anupam Rasayan India comes out ahead on size, growth and financial health. Privi Speciality Chemicals comes out ahead on valuation, profitability, momentum and technicals. Across the scored metrics below, Anupam Rasayan India leads on 6 and Privi Speciality Chemicals on 10. On StoxGud's 10-point checklist, Anupam Rasayan India scores 4/10 and Privi Speciality Chemicals scores 8/10.
| Metric | Anupam Rasayan India | Privi Speciality Chemicals |
|---|---|---|
| Size | ||
| Market cap | ₹13,266 Cr | ₹13,145 Cr |
| Revenue (latest FY) | ₹2,365 Cr | ₹2,564 Cr |
| Net profit (latest FY) | ₹170 Cr | ₹0 Cr |
| Valuation | ||
| P/E | 75.9 | 47.1 |
| P/B | 3.98 | 8.35 |
| Dividend yield | 0.11% | 0.15% |
| Profitability | ||
| Return on equity | 5.2% | 17.7% |
| Net profit margin | 6.9% | 10.1% |
| Operating margin | 22.2% | 24.8% |
| Growth | ||
| Revenue growth (YoY) | +34.8% | +12.0% |
| Net profit growth (YoY) | +13.5% | — |
| Revenue CAGR (multi-year) | +23.9% | +15.0% |
| Financial health | ||
| Debt to equity | 0.54 | 0.62 |
| Momentum | ||
| 1-month return | +0.0% | -4.4% |
| 1-year return | +7.0% | +17.8% |
| 3-year CAGR | +8.7% | +37.8% |
| 5-year CAGR | +7.4% | +14.2% |
| 10-year CAGR | — | +20.8% |
| Distance from 52W high | -15.3% | -10.3% |
| Technicals | ||
| RSI (14) | 48 | 51 |
| Price vs 200-day avg | -7.1% | +3.0% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Anupam Rasayan India | Privi Speciality Chemicals |
|---|---|---|
| Price above 50-day average | ✗ | ✗ |
| Price above 200-day average | ✗ | ✓ |
| 50-day average above 200-day (uptrend) | ✗ | ✓ |
| RSI in healthy 40–70 zone | ✓ | ✓ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✗ | ✓ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✗ | ✓ |
| P/E below industry median | ✗ | ✗ |
| Score | 4/10 | 8/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Anupam Rasayan India or Privi Speciality Chemicals?
Anupam Rasayan India has a market cap of ₹13,266 Cr and Privi Speciality Chemicals has a market cap of ₹13,145 Cr as of 06 Nov 2026.
Which has a lower P/E, Anupam Rasayan India or Privi Speciality Chemicals?
Privi Speciality Chemicals has the lower P/E: Anupam Rasayan India trades at 75.9 and Privi Speciality Chemicals at 47.1.
Which gave better returns in the last year, Anupam Rasayan India or Privi Speciality Chemicals?
Privi Speciality Chemicals did better: Anupam Rasayan India returned +7.0% and Privi Speciality Chemicals returned +17.8% over one year.
Is Anupam Rasayan India or Privi Speciality Chemicals a better buy?
StoxGud does not give buy or sell recommendations. On our rules-based checklist Anupam Rasayan India scores 4/10 and Privi Speciality Chemicals scores 8/10; compare valuation, profitability, growth and momentum above and consult a SEBI-registered adviser.